Garstang Medical Services Limited - Period Ending 2019-03-31

Garstang Medical Services Limited - Period Ending 2019-03-31


Garstang Medical Services Limited 05015346 false 2018-04-01 2019-03-31 2019-03-31 The principal activity of the company is a dispensing pharmacy Digita Accounts Production Advanced 6.24.8820.0 Software true 05015346 2018-04-01 2019-03-31 05015346 2019-03-31 05015346 core:CapitalRedemptionReserve 2019-03-31 05015346 core:RetainedEarningsAccumulatedLosses 2019-03-31 05015346 core:ShareCapital 2019-03-31 05015346 core:CurrentFinancialInstruments 2019-03-31 05015346 core:CurrentFinancialInstruments core:WithinOneYear 2019-03-31 05015346 core:Non-currentFinancialInstruments 2019-03-31 05015346 core:Non-currentFinancialInstruments core:AfterOneYear 2019-03-31 05015346 core:FurnitureFittingsToolsEquipment 2019-03-31 05015346 core:LandBuildings 2019-03-31 05015346 core:MotorVehicles 2019-03-31 05015346 core:OtherPropertyPlantEquipment 2019-03-31 05015346 bus:SmallEntities 2018-04-01 2019-03-31 05015346 bus:AuditExemptWithAccountantsReport 2018-04-01 2019-03-31 05015346 bus:FullAccounts 2018-04-01 2019-03-31 05015346 bus:SmallCompaniesRegimeForAccounts 2018-04-01 2019-03-31 05015346 bus:RegisteredOffice 2018-04-01 2019-03-31 05015346 bus:Director3 2018-04-01 2019-03-31 05015346 bus:PrivateLimitedCompanyLtd 2018-04-01 2019-03-31 05015346 bus:Agent1 2018-04-01 2019-03-31 05015346 core:FurnitureFittings 2018-04-01 2019-03-31 05015346 core:FurnitureFittingsToolsEquipment 2018-04-01 2019-03-31 05015346 core:LandBuildings 2018-04-01 2019-03-31 05015346 core:MotorVehicles 2018-04-01 2019-03-31 05015346 core:OtherPropertyPlantEquipment 2018-04-01 2019-03-31 05015346 core:PlantMachinery 2018-04-01 2019-03-31 05015346 countries:AllCountries 2018-04-01 2019-03-31 05015346 2018-03-31 05015346 core:FurnitureFittingsToolsEquipment 2018-03-31 05015346 core:LandBuildings 2018-03-31 05015346 core:MotorVehicles 2018-03-31 05015346 core:OtherPropertyPlantEquipment 2018-03-31 05015346 2017-04-01 2018-03-31 05015346 2018-03-31 05015346 core:CapitalRedemptionReserve 2018-03-31 05015346 core:RetainedEarningsAccumulatedLosses 2018-03-31 05015346 core:ShareCapital 2018-03-31 05015346 core:CurrentFinancialInstruments 2018-03-31 05015346 core:CurrentFinancialInstruments core:WithinOneYear 2018-03-31 05015346 core:Non-currentFinancialInstruments 2018-03-31 05015346 core:Non-currentFinancialInstruments core:AfterOneYear 2018-03-31 05015346 core:FurnitureFittingsToolsEquipment 2018-03-31 05015346 core:LandBuildings 2018-03-31 05015346 core:MotorVehicles 2018-03-31 05015346 core:OtherPropertyPlantEquipment 2018-03-31 iso4217:GBP xbrli:pure

REGISTRAR OF COMPANIES

Registration number: 05015346

Garstang Medical Services Limited

Unaudited Financial Statements

31 March 2019

image-name

 

Garstang Medical Services Limited

Contents

Accountants' Report

1

Balance Sheet

2

Notes to the Financial Statements

4

 

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Garstang Medical Services Limited
for the Year Ended 31 March 2019

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Garstang Medical Services Limited for the year ended 31 March 2019 as set out on pages 2 to 10 from the company's accounting records and from information and explanations you have given us.

As a member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/membershandbook.

This report is made solely to the Board of Directors of Garstang Medical Services Limited, as a body, in accordance with the terms of our engagement letter dated 13 August 2018. Our work has been undertaken solely to prepare for your approval the accounts of Garstang Medical Services Limited and state those matters that we have agreed to state to the Board of Directors of Garstang Medical Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Garstang Medical Services Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Garstang Medical Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Garstang Medical Services Limited. You consider that Garstang Medical Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Garstang Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.



Dodd & Co Limited
Chartered Accountants
Clint Mill
Cornmarket
PENRITH
CA11 7HW

18 July 2019

 

Garstang Medical Services Limited

(Registration number: 05015346)
Balance Sheet as at 31 March 2019

Note

2019
£

2018
£

Fixed assets

 

Tangible assets

4

288,885

53,946

Current assets

 

Stocks

68,004

119,612

Debtors

5

696,431

932,882

Cash and cash equivalents

 

199,069

97,248

 

963,504

1,149,742

Creditors: Amounts falling due within one year

6

(1,010,873)

(1,180,044)

Net current liabilities

 

(47,369)

(30,302)

Total assets less current liabilities

 

241,516

23,644

Creditors: Amounts falling due after more than one year

6

(160,695)

(5,318)

Provisions for liabilities

(48,587)

(3,518)

Net assets

 

32,234

14,808

Capital and reserves

 

Allotted, called up and fully paid share capital

500

350

Capital redemption reserve

125

125

Profit and loss account

31,609

14,333

Total equity

 

32,234

14,808

 

Garstang Medical Services Limited

(Registration number: 05015346)
Balance Sheet as at 31 March 2019 (continued)

For the financial year ending 31 March 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 18 July 2019
 

.........................................

Dr J T Williamson

Director

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2019

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Garstang Medical Centre
Kepple Lane
Garstang
PRESTON
PR3 1PB

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The company has net current liabilities at 31 March 2019 and meets its day to day working capital requirements through its bank overdraft facility which, in common with all such facilities, is repayable on demand. In addition the directors have provided financial support by way of short term loans. On the basis of this support, the directors consider it appropriate to prepare the financial statements on the going concern basis.

However, should the company not have the support of its bankers, and therefore be unable to continue trading, adjustments would have to be made to reduce the value of assets to their recoverable amounts, to provide for any further liabilities which might arise, and to reclassify fixed assets and long term liabilities as current assets and current liabilities.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when the amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2019 (continued)


Other grants
Other grants in respect of capital expenditure are credited to a deferred income account and are released to profit over the expected useful lives of the relevant assets on a basis consistent with the depreciation policy.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and equipment

15% straight line

Fixtures, fittings and office equipment

15% straight line

Land and buildings

Straight line over 24 years

Motor vehicles

25% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2019 (continued)

Trade debtors

Trade debtors are amounts due from customers for the sale of goods or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method where due after more than one year.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2019 (continued)

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the Profit and Loss Account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 50 (2018 - 49).

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2019 (continued)

4

Tangible assets

Land and buildings
£

Plant and equipment
 £

Motor vehicles
 £

Furniture, fittings and office equipment
 £

Total
£

Cost or valuation

At 1 April 2018

60,036

73,436

25,070

38,003

196,545

Additions

36,864

212,939

-

955

250,758

Disposals

-

-

(1,500)

-

(1,500)

At 31 March 2019

96,900

286,375

23,570

38,958

445,803

Depreciation

At 1 April 2018

27,522

67,138

14,480

33,459

142,599

Charge for the year

3,210

8,300

2,552

1,371

15,433

Eliminated on disposal

-

-

(1,114)

-

(1,114)

At 31 March 2019

30,732

75,438

15,918

34,830

156,918

Carrying amount

At 31 March 2019

66,168

210,937

7,652

4,128

288,885

At 31 March 2018

32,514

6,298

10,590

4,544

53,946

5

Debtors

2019
£

2018
£

Trade debtors

679,568

921,274

Other debtors

16,863

11,608

696,431

932,882

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2019 (continued)

6

Creditors

Note

2019
£

2018
£

Due within one year

 

Loans and borrowings

7

43,103

2,659

Trade creditors

 

905,705

1,086,946

Taxation and social security

 

15,704

13,386

Corporation tax liability

 

39,990

68,587

Other creditors

 

6,371

8,466

 

1,010,873

1,180,044

Due after one year

 

Loans and borrowings

7

160,695

5,318

7

Loans and borrowings

2019
£

2018
£

Current loans and borrowings

Bank borrowings

8,062

-

Finance lease liabilities

35,041

2,659

43,103

2,659

Current bank borrowings are secured by a fixed and floating charge over all assets of the company.

Current finance lease liabilities are secured on the assets to which they relate.

2019
£

2018
£

Non-current loans and borrowings

Bank borrowings

33,906

-

Finance lease liabilities

126,789

5,318

160,695

5,318

Non-current loans and borrowings includes the following liabilities, on which security has been given by the company:

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2019 (continued)

2019
£

2018
£

Bank borrowings

33,906

-

Finance lease liabilities

126,789

5,318

160,695

5,318

Non-current bank borrowings are secured by a fixed and floating charge over all assets of the company.

Non-current finance lease liabilities are secured on the assets to which they relate.